Publications

Results 3001 to 3012 of 3980

20 September 2012

European Monitoring Centre on Drugs and Drug Addiction strategy and work programme 2013-2015

The bedrock on which this three-year strategy and work plan rests is the recognition that the achievements the agency has made since its inception have been delivered by maintaining clarity of purpose, technical rigour and a long-term vision.

20 September 2012

ANCD Position Statement: Expanding naloxone availability

This position statement makes a case for the provision of naloxone and the training of potential overdose witnesses in the use of the substance in order to prevent overdose related deaths.

20 September 2012

EMCDDA guidelines for reporting data on people entering drug treatment in European countries

Reflecting the nature of today’s drugs problem, the protocol presents a number of new items on polydrug use, new psychoactive substances, infectious diseases, risk behaviours and substitution treatment.

20 September 2012

Bridging the gap: Why the European Union must address the Global Fund’s funding crisis to tackle the escalating HIV and TB epidemics in Eastern Europe and Central Asia

The report calls on the EU to step in to fill the gaps left by global donors to countries within and neighbouring its borders.

10 September 2012

IDPC/EHRN briefing paper - Policing people who inject drugs: Evidence from Eurasia

The purpose of this briefing paper is to review up-to-date evidence on the institutionalisation of police violence toward people who use drugs across the region and the implications of these practices for public health and society.

10 September 2012

Report of TNI/IDPC Expert seminar on the future of the UN drug conventions

The discussions around treaty reform at the seminar aimed to facilitate a wide spectrum of approaches to drugs.

10 September 2012

Alternatives to prohibition - Illicit drugs: How can we stop killing and criminalising young Australians

This report follows from a Roundtable discussion held in July 2012 to consider new approaches to public policy about illicit drugs in Australia.

7 September 2012

Travel and drug use in Europe: a short EMCDDA review

Little is known about the issue of drug use by travellers. This Thematic paper seeks to increase the interest in this topic both in terms of research and of developing adequate responses to problems related to drugs and travel.

6 September 2012

The economic impact of Hepatitis C in Australia

The report concludes that investment in new hepatitis C treatment will cure more people of a chronic and costly condition and provide substantial economic benefits for society in the long term

5 September 2012

TNI/Diogenis report on Prague informal drug policy dialogue

Four themes were discussed during the dialogue: the European Union drug policy agenda, cannabis policy reform, the future of the UN drug control conventions and the upcoming 55th Session of the Commission on Narcotic Drugs.

5 September 2012

Assessment of medication assisted therapy programme in Kazakhstan

The purpose of this assessment was to collect information on the scale and quality of the existing MAT services for people who inject drugs in Kazakhstan, and to identify any gaps in such services.

3 September 2012

Joint position paper of civil society organisations on the Global Fund new funding model

This position paper informs members of the Global Fund Strategy, Investment and Impact Committee about issues which should be considered when making a decision regarding options for the Global Fund's new funding mechanism.